The global low dosage hydrate inhibitors (LDHIs) market size is expected to grow substantially due to the heightening demand for safety & security in the oil & gas industry. Fortune Business Insights™ shares this information in its latest report, titled “Low Dosage Hydrate Inhibitors (LDHIs) Market, 2021-2028.”

Heating and safety concerns due to congestions caused in pipes are rising in several offshore hydrocarbon operations. Low dosage hydrate inhibitors delay the formation of gas hydrates and regulate the temperature and ensure the free and safe flow of oils, gases, and other liquids. Various LDHI technologies, such as kinetic inhibitors (KHI) and anti-agglomerate (AA) inhibitors, can be used as per the consumer requirement and cost-efficient solutions that provide excellent control of temperatures and prevent hydrate formation to ensure that pipelines and flowlines are safe from icy blockages and ruptures. Therefore, due to the enhanced security and safety features of the LDHI technology, its adoption has been steadily expanding in the fossil fuel industry, driving the growth of the market in the process.

Get Sample PDF Brochure:-

Market Segmentation

By type, the market is segmented into anti-agglomerate (AA) inhibitors and kinetic hydrate inhibitors (KHI). Based on application, it is segregated into onshore and offshore. Geographically, it is grouped into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Highlights of the Report

The report analyzes the top segments and latest trends influencing the market. It comprehensively discusses the impact of COVID-19 and the driving and restraining factors of the market. Additionally, it offers an in-depth study of the various strategies implemented by key players and projections about the regional developments that may impact the market.

Drivers and Restraints

Initiation of Major Oil & Gas Projects to Create Ideal Growth Conditions for the Market

Oil and gas continue to be the primary energy resources for the world and are expected to retain their position over the next couple of decades, according to the International Energy Agency (IEA). The widespread reliance on hydrocarbons is leading to the initiation of large-scale exploration and production projects around the globe. For example, the Alaska LNG Plant costs USD 43 billion and will export approximately 3.5 billion cubic feet of gas per day from the state’s North Slope gas fields. To take another example, Kuwait’s Al Zour is one of the world’s biggest refineries, producing 100,000 barrels of low-sulfur fuel oil every day as feedstock for power generation. Low dosage hydrate inhibitors are set to play an instrumental role in the production of hydrocarbons at these facilities, as LDHIs interfere with the crystallization process of gas hydrates and delay their formation, providing a longer shelf life for the pipes.

Regional Insights

Rapidly Growing Oil & Gas Industry to Fuel the Demand for LDHIs in Asia Pacific

Asia Pacific is expected to dominate the low dosage hydrate inhibitor market share owing to the swiftly increasing demand for anti-hydrate formation solutions in several industries in the region to enhance the flow of oils in pipes. This demand is underpinned by the surging need for fossil fuels, mainly oil, in the region’s speedily developing economies, such as India, China, and Vietnam.

The market in Europe is anticipated to grow immensely during the forecast period due to the rising demand for low dosage hydrate inhibitors for several onshore exploration and production operations. The North America market, meanwhile, is envisaged to progress because of the rising adoption of anti-agglomerate (AA) inhibitors for the region’s offshore operations for shale gas.

Competitive Landscape

Key Players to Develop LDHI Solutions for Enhanced Employee Safety

The development of enhanced low dosage hydrate inhibitors has enabled players to maintain the safety of their employees whilst boosting their production capacity. For example, an Ecolab company named Nalco Champion expanded its portfolio of low-dosage hydrates in the Gulf of Mexico in September 2016 and enabled the company to reduce accidents, abridge logistical data, augment production, and reduce costs. Additionally, companies have invested on research and development to create high-quality LDHI solutions.

List of Key Players Covered in the Low Dosage Hydrate Inhibitors Market Report

  • Schlumberger
  • Ashland
  • Halliburton
  • Baker Huges a GE Company (BHGE)
  • Arkema
  • Nalco (Ecolab)
  • Clariant

Read Related News:

Demulsifier Market Latest Industry Size, Growth, Share, Demand, Trends, Competitive Landscape and Forecasts to 2027

Europe Polypropylene Market Size, Outlook, Geographical Segmentation, Business Challenges and Opportunities till 2027

Technical Textiles Market Size, Gross Margin, Trends, Future Demand, Analysis by Top Leading Players and Forecast till 2027

Protective Coatings Market Key Drivers, Restraints, Industry Size & Share, Opportunities, Trends, and Forecasts up to 2027


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.


Fortune Business Insights Pvt. Ltd.9th Floor, Icon Tower, Baner –

Mahalunge Road, Baner, Pune-411045,

Maharashtra, India.


US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: [email protected]

LinkedIn Facebook Twitter